The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders
Version 2 2024-05-30, 08:33Version 2 2024-05-30, 08:33
Version 1 2014-10-28, 10:17Version 1 2014-10-28, 10:17
journal contribution
posted on 2024-05-30, 08:33authored byI Pacchiarotti, DJ Bond, RJ Baldessarini, WA Nolen, H Grunze, RW Licht, RM Post, Michael BerkMichael Berk, GM Goodwin, GS Sachs, L Tondo, RL Findling, EA Youngstrom, M Tohen, J Undurraga, A González-Pinto, JF Goldberg, A Yildiz, LL Altshuler, JR Calabrese, PB Mitchell, ME Thase, A Koukopoulos, F Colom, MA Frye, GS Malhi, KN Fountoulakis, G Vázquez, RH Perlis, TA Ketter, F Cassidy, H Akiskal, JM Azorin, M Valentí, DH Mazzei, B Lafer, T Kato, L Mazzarini, A Martínez-Aran, G Parker, D Souery, A Özerdem, SL McElroy, P Girardi, M Bauer, LN Yatham, CA Zarate, AA Nierenberg, B Birmaher, S Kanba, RS El-Mallakh, A Serretti, Z Rihmer, AH Young, GD Kotzalidis, GM Macqueen, CL Bowden, SN Ghaemi, C Lopez-Jaramillo, J Rybakowski, K Ha, G Perugi, S Kasper, JD Amsterdam, RM Hirschfeld, F Kapczinski, E Vieta
The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders